Related Experiment Video
Updated: Aug 5, 2026
07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Behçet's disease and breast cancer: A case series study
Fatih Karatas1, Suleyman Sahin1, Aydin Aytekin2
1Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Training Hospital, Ankara, Turkey.
Journal of Cancer Research and Therapeutics
|November 30, 2018
Summary
Behçet's disease (BD) did not increase adverse events in breast cancer (BC) patients. However, further research is needed to understand the relationship between these conditions due to the small sample size.
Area of Science:
- Oncology
- Rheumatology
- Immunology
Background:
- The relationship between Behçet's disease (BD) and breast cancer (BC) remains unclear.
- Investigating a potential bidirectional effect between BD and BC is crucial.
Purpose of the Study:
- To determine if Behçet's disease impacts breast cancer development or progression.
- To assess if breast cancer influences the course of Behçet's disease.
Main Methods:
- A retrospective analysis of 12 female breast cancer patients with a prior Behçet's disease diagnosis.
- Examined demographic data, treatment history (chemotherapy, radiotherapy, hormonal therapy), BD medications, thrombotic events, and survival.
Main Results:
- Behçet's disease was present in 0.25% of the breast cancer cohort; all patients had early-stage breast cancer.
- Patients received standard breast cancer treatments; all took acetylsalicylic acid and colchicine for BD.
- No serious adverse events were noted; BD symptoms improved in most patients post-breast cancer treatment.
Conclusions:
- Breast cancer patients with Behçet's disease in this cohort did not experience increased thrombotic events, contrary to BD's typical profile.
- The small sample size limits definitive conclusions on the interplay between breast cancer and Behçet's disease.
